hydroxyprogesterone caproate (USP)

Known as: caproate hydroxyprogesterone, 17-alpha-hydroxy-progesterone caproate, Hydroxyprogesterone Caproate 
A synthetic progestational agent similar to the endogenous progesterone used in hormone therapy or as a female contraceptive. Mimicking the action of… (More)
National Institutes of Health

Related topics

Related topics

19 relations
1 ML hydroxyprogesterone caproate (USP) 250 MG/ML Injection [Makena]AmenorrheaDrug AllergyEndometriosis
(More)

Broader (4)

17-alpha-HydroxyprogesteroneEstrogen AntagonistsHydroxyprogesteronesProgestins

Narrower (3)

DelalutinNeolutinProlutin Depot

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.
OBJECTIVE We sought to evaluate whether 17 alpha-hydroxyprogesterone caproate (17-OHP) reduces preterm birth (PTB) in nulliparous… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2011
2011
17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial.
OBJECTIVE We sought to determine whether prophylactic treatment with 17-alpha-hydroxyprogesterone caproate (17Pc) in twin… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2010
2010
Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis.
OBJECTIVE The purpose of this study was to estimate which strategy is the most cost-effective for the prevention of preterm birth… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2010
2010
Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial.
OBJECTIVE To assess whether the addition of an omega-3 long-chain polyunsaturated fatty acid supplement would reduce preterm… (More)
Is this relevant?
2010
2010
Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial.
OBJECTIVE To test whether 17 alpha-hydroxyprogesterone caproate (17P) will reduce neonatal morbidity by increasing gestational… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.
BACKGROUND In singleton gestations, 17 alpha-hydroxyprogesterone caproate (17P) has been shown to reduce the rate of recurrent… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States.
OBJECTIVE A multicenter, randomized placebo-controlled trial among women with singleton pregnancies and a history of spontaneous… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
 
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Progestogen administration in pregnancy may prevent preterm delivery.
Two recently published meta-analyses of controlled trials of a wide variety of progestational agents, used in pregnancy (Daya… (More)
Is this relevant?
1986
1986
Frequent occurrence of polyovular follicles in ovaries of mice exposed neonatally to diethylstilbestrol.
The occurrence of polyovular follicles (PF) was examined at 10-34 days of age in the ovaries of BALB/cCrgl female mice given five… (More)
Is this relevant?